Syren Biotech: Announcement on preparing for impairment of long-term equity investments
Syren Biotech: third quarter report 2024
Syren Biotech: Announcement on holding the results briefing for the third quarter of 2024
Syren Biotech: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior management and securities affairs representatives
Syren Biotech: Announcement of Resolutions of the First Meeting of the Fourth Board of Supervisors
Legal Opinion of Shanghai AllBright Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Serun Biotechnology Co., Ltd.
Cyron Biotech: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Syren Biotech: Announcement on Election of Staff Representative Supervisors for the 4th Board of Supervisors
Syren Biotech: Investor Relations Activity Record Form (September 2024)
Syren Biotech: 2024 First Extraordinary General Meeting of Shareholders Meeting Information
Syren Biotech: Announcement on holding a briefing on 2024 semi-annual results and cash dividends
Cyron Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Syren Biotech: Board Nomination Committee\'s Review of the Eligibility of Independent Director Candidates for the 4th Board of Directors
Independent Director Nominee\'s Statement and Commitment (Ye Yunping)
Independent Director Nominee\'s Statement and Commitment (Liu Junling)
Independent Director Nominee\'s Statement and Commitment (Fu Yishang)
Independent Director Candidate Statement and Commitment (Ye Yunping)
Independent Director Candidate Statements and Commitments (Liu Junling)
Independent Director Candidate Statement and Commitment (Fu Yishang)
Syren Biotech: Announcement on the election of the Board of Directors and the Board of Supervisors